Skip to main content


Figure 2 | BMC Infectious Diseases

Figure 2

From: Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country

Figure 2

QuantiFERON-TB Gold responses in latent tuberculosis during preventive therapy. Interferon gamma responses (IU/ml) before (baseline, n = 44), after three months (at the end of therapy, n = 40) and after 15 months (one year after ended therapy, n = 26) in patients with latent tuberculosis treated with isoniazid and rifampicin.

Back to article page